These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 25825738

  • 21. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
    Wang X.
    Cell Cycle; 2011 Dec 15; 10(24):4225-9. PubMed ID: 22134240
    [Abstract] [Full Text] [Related]

  • 22. MdmX protects p53 from Mdm2-mediated degradation.
    Jackson MW, Berberich SJ.
    Mol Cell Biol; 2000 Feb 15; 20(3):1001-7. PubMed ID: 10629057
    [Abstract] [Full Text] [Related]

  • 23. MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.
    Huang Q, Chen L, Yang L, Xie X, Gan L, Cleveland JL, Chen J.
    Proc Natl Acad Sci U S A; 2018 Apr 10; 115(15):E3368-E3377. PubMed ID: 29581299
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 1H, 15N and 13C backbone resonance assignments of the acidic domain of the human MDMX protein.
    Song Q, Liu XQ, Rainey JK.
    Biomol NMR Assign; 2022 Apr 10; 16(1):171-178. PubMed ID: 35359247
    [Abstract] [Full Text] [Related]

  • 27. High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.
    Czarna A, Popowicz GM, Pecak A, Wolf S, Dubin G, Holak TA.
    Cell Cycle; 2009 Apr 15; 8(8):1176-84. PubMed ID: 19305137
    [Abstract] [Full Text] [Related]

  • 28. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K, Kashima K, Pereg Y, Ishida M, Yamazaki S, Nota A, Teunisse A, Migliorini D, Kitabayashi I, Marine JC, Prives C, Shiloh Y, Jochemsen AG, Taya Y.
    Mol Cell Biol; 2005 Nov 15; 25(21):9608-20. PubMed ID: 16227609
    [Abstract] [Full Text] [Related]

  • 29. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
    Qin L, Yang F, Zhou C, Chen Y, Zhang H, Su Z.
    J Am Chem Soc; 2014 Dec 31; 136(52):18023-33. PubMed ID: 25453499
    [Abstract] [Full Text] [Related]

  • 30. Abnormal MDMX degradation in tumor cells due to ARF deficiency.
    Li X, Gilkes D, Li B, Cheng Q, Pernazza D, Lawrence H, Lawrence N, Chen J.
    Oncogene; 2012 Aug 09; 31(32):3721-32. PubMed ID: 22120712
    [Abstract] [Full Text] [Related]

  • 31. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P, McCormick F.
    DNA Cell Biol; 2002 Jul 09; 21(7):519-25. PubMed ID: 12162806
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins.
    Soares J, Raimundo L, Pereira NA, dos Santos DJ, Pérez M, Queiroz G, Leão M, Santos MM, Saraiva L.
    Pharmacol Res; 2015 Jul 09; 95-96():42-52. PubMed ID: 25814188
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction.
    Fasan R, Dias RL, Moehle K, Zerbe O, Vrijbloed JW, Obrecht D, Robinson JA.
    Angew Chem Int Ed Engl; 2004 Apr 13; 43(16):2109-12. PubMed ID: 15083458
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.